Transcenta Holding Limited (HKG:6628)
Hong Kong · Delayed Price · Currency is HKD 2.650
-0.070 (-2.57%)
Apr 17, 2026, 4:08 PM HKT
Transcenta Holding Market Cap
Transcenta Holding has a market cap or net worth of 1.19 billion as of April 17, 2026. Its market cap has increased by 47.47% in one year.
Market Cap
1.19B
Enterprise Value
1.31B
Revenue
8.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.65
Market Cap Chart
Since April 27, 2022, Transcenta Holding's market cap has decreased from 2.75B to 1.19B, a decrease of -56.71%. That is a compound annual growth rate of -19.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 1.22B | 28.30% |
| Dec 31, 2025 | 953.77M | 274.36% |
| Dec 31, 2024 | 254.77M | -82.96% |
| Dec 29, 2023 | 1.50B | 14.88% |
| Dec 30, 2022 | 1.30B | -52.74% |
| Apr 27, 2022 | 2.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cutia Therapeutics | 1.71B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.70B |
| Zhaoke Ophthalmology | 1.67B |
| CANbridge Pharmaceuticals | 1.57B |
| Kintor Pharmaceutical | 1.46B |
| Beijing Biostar Pharmaceuticals | 1.29B |
| Brii Biosciences | 1.02B |
| Shanghai Bio-heart Biological Technology | 1.02B |